Real-time enrollment status for this treatment-resistant depression (trd) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:04 PM UTC
| NCT Number | NCT07553637 |
| Recruiting Status | Recruiting |
| Condition | Treatment-resistant Depression (TRD) |
| Phase | PHASE2 |
| Target Enrollment | 178 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Alto Neuroscience |
| Last Updated on CT.gov | April 28, 2026 (Apr 28, 2026) |
As of August 28, 2026: Clinical trial NCT07553637 is currently recruiting participants. This phase2 study for treatment-resistant depression (trd) is actively seeking new participants at 38 locations across the United States. The study is sponsored by Alto Neuroscience. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07553637 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07553637 was last updated Apr 28, 2026 (April 28, 2026). HelloStudys verifies this status automatically.